HbA1c≤ 7% | 73/136 (54) | 67/111 (60) | 69/106 (65) | 78/109 (72) | 62/84 (74) | .0003 |
LDL ≤ 2.0 mmol/L | 57/112 (51) | 44/82 (54) | 45/89 (51) | 55/85 (65) | 41/72 (57) | .15 |
Test for microalbuminuria done in past 6 mo or ordered at the visit | 44/145 (30) | 49/142 (35) | 52/130 (40) | 54/126 (43) | 47/102 (46) | .003 |
BP < 130/80 mm Hg in patients for whom microalbuminuria was absent (ACR < 2.0 mg/mmol in men or < 2.8 mg/mmol in women) or unreported† | 21/69 (30) (microalbuminuria absent or unreported, N = 107) | 26/80 (33) (microalbuminuria absent or unreported, N = 111) | 30/83 (36) (microalbuminuria absent or unreported, N = 105) | 33/84 (39) (microalbuminuria absent or unreported, N = 93) | 20/55 (36) (microalbuminuria absent or unreported, N = 71) | .27 |
BP < 125/75 mm Hg in patients for whom microalbuminuria was present† | 4/30 (13) (microalbuminuria present, N = 38) | 5/24 (21) (microalbuminuria present, N = 31) | 5/21 (24) (microalbuminuria present, N = 25) | 8/32 (25) (microalbuminuria present, N = 33) | 6/29 (21) (microalbuminuria present, N = 31) | .4 |
Currently taking ASA or ASA use was recommended at the visit | 114/145 (79) | 104/142 (73) | 89/130 (68) | 86/126 (68) | 68/102 (67) | .019 |
Currently taking an ACEI or ARB, or ACEI or ARB use was recommended, in patients with BP ≥ 130 mm Hg or where microalbuminuria was present | 68/86 (79) | 68/85 (80) | 64/78 (82) | 59/84 (70) | 47/66 (71) | .09 |